178 related articles for article (PubMed ID: 34540006)
1. NRP2, a potential biomarker for oral squamous cell carcinoma.
Kang Y; Zhang Y; Zhang Y; Sun Y
Am J Transl Res; 2021; 13(8):8938-8951. PubMed ID: 34540006
[TBL] [Abstract][Full Text] [Related]
2. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis.
Zhang B; Gao Z; Sun M; Li H; Fan H; Chen D; Zheng J
J Surg Oncol; 2015 Mar; 111(4):382-8. PubMed ID: 25475162
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients.
Ong HS; Gokavarapu S; Xu Q; Tian Z; Li J; Ji T; Zhang CP
Int J Oral Maxillofac Surg; 2017 Oct; 46(10):1205-1219. PubMed ID: 28602571
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of neuropilin-2 associated with unfavorable prognosis in hepatocellular carcinoma.
Dong X; Guo W; Zhang S; Wu T; Sun Z; Yan S; Zheng S
Onco Targets Ther; 2017; 10():3827-3833. PubMed ID: 28814881
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
Liu M; Gao X; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
[TBL] [Abstract][Full Text] [Related]
8. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
[TBL] [Abstract][Full Text] [Related]
9. Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression.
Yasuoka H; Kodama R; Tsujimoto M; Yoshidome K; Akamatsu H; Nakahara M; Inagaki M; Sanke T; Nakamura Y
BMC Cancer; 2009 Jul; 9():220. PubMed ID: 19580679
[TBL] [Abstract][Full Text] [Related]
10. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma.
Xu X; Dai Y; Feng L; Zhang H; Hu Y; Xu L; Zhu X; Jiang Y
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):527-535. PubMed ID: 32400862
[TBL] [Abstract][Full Text] [Related]
12. [Expression and prognostic value of IL-6 and β-catenin in oral squamous cell carcinoma].
Dong LS; Tang J; Cheng W; Ran JX; Liu ZB; Li YD
Shanghai Kou Qiang Yi Xue; 2023 Jun; 32(3):280-286. PubMed ID: 37803984
[TBL] [Abstract][Full Text] [Related]
13. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-2 expression in papillary thyroid carcinoma: correlation with VEGF-D expression, lymph node metastasis, and VEGF-D-induced aggressive cancer cell phenotype.
Yasuoka H; Kodama R; Hirokawa M; Takamura Y; Miyauchi A; Inagaki M; Sanke T; Nakamura Y
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1857-61. PubMed ID: 21880798
[TBL] [Abstract][Full Text] [Related]
15. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
Wei H; Yu K; Liu Y; Li L; Wang G
BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma.
Jing Y; Zhou Q; Zhu H; Zhang Y; Song Y; Zhang X; Huang X; Yang Y; Ni Y; Hu Q
Oncol Lett; 2019 Jan; 17(1):974-980. PubMed ID: 30655856
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of FOXD1 is associated with cervical node metastasis and unfavorable prognosis in oral squamous cell carcinoma.
Li Z; Yan T; Wu X; Zhang W; Li J; Wang L; Yang J
J Oral Pathol Med; 2020 Nov; 49(10):1030-1036. PubMed ID: 32808339
[TBL] [Abstract][Full Text] [Related]
18.
Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3278-3285. PubMed ID: 31379206
[No Abstract] [Full Text] [Related]
19. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
20. RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma.
Zhou WN; Du YF; Bai J; Song XM; Zheng Y; Yuan H; Zhang W; Zhang ZD; Wu YN
Oncol Rep; 2017 Oct; 38(4):2378-2386. PubMed ID: 28765934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
